📰 Vered Caplan News
Vered Caplan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vered Caplan. Real-time updates on events, politics, business and more.
January 31, 2024
Orgenesis Inc (NASDAQ:ORGS) has entered into a definitive agreement with MM OS Holdings, an affiliate of Metalmark Capital Partners, to acquire its approximate 25% stake in Octomera. Octomera is Orgenesis’s cell processing services subsidiary, and the transaction allows the company to have 100% ownership of this business unit. In exchange, Metalmark will receive a royalty of 5% of the net revenue of Octomera’s cell processing services for the three calendar years 2025-2027, along w...
January 31, 2024
Orgenesis to acquire full ownership of Octomera & Metalmark to receive royalty & proceeds in exchange. Shift to decentralized production supported by regulators.
November 14, 2023
Advances rollout of POCare Platform and POCare Therapies...
August 11, 2023
Reports Progress in Advancing the Rollout of the POCare Platform and POCare Therapeutic PipelineOrgenesis to Host Conference Call Today at 8:00 AM...
July 11, 2023
Name Change and Rebranding Reflects Progression of the Business and Focus on Changing the Paradigm of CGT Production GERMANTOWN, Md., July 11, 2023 (GLOBE…
July 4, 2023
Morgenesis LLC, the US point of care (POCare) services subsidiary of global cell and gene therapies developer biotech Orgenesis, has signed an agreement with contract development and manufacturing organisation SCTbio to open new POCare sites within the Czech Republic. Click to read more...
June 7, 2023
Orgenesis and University of California, Davis sign partnership agreement for rollout of cell and gene therapy mobile processing units and labs throughout California Germantown, Maryland and Davis, California, US, June 7, 2023 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company&r...
May 30, 2023
30.05.2023 - GERMANTOWN, Md., May 30, 2023 (GLOBE NEWSWIRE) - Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), today announced that cell and gene ... Seite 1
May 22, 2023
GERMANTOWN, Md., May 22, 2023 -- Orgenesis Inc. , a global biotech company working to unlock the full potential of cell and gene therapies , today announced the first graduating class from a... | May 22, 2023
May 19, 2023
GERMANTOWN, Md., May 19, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to...